1724 related articles for article (PubMed ID: 28590439)
1. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
Spoerl D; Nigolian H; Czarnetzki C; Harr T
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
[TBL] [Abstract][Full Text] [Related]
2. Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones.
Elst J; Maurer M; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; van der Poorten MM; De Puysseleyr LP; Hagendorens MM; Van Tendeloo VF; Lion E; Campillo-Davo D; Ebo DG
Front Immunol; 2021; 12():668962. PubMed ID: 34385999
[TBL] [Abstract][Full Text] [Related]
3. Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions.
Porebski G; Kwiecien K; Pawica M; Kwitniewski M
Front Immunol; 2018; 9():3027. PubMed ID: 30619367
[TBL] [Abstract][Full Text] [Related]
4. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs.
Ali H
Curr Opin Immunol; 2021 Oct; 72():65-71. PubMed ID: 33857758
[TBL] [Abstract][Full Text] [Related]
6. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: Modulation by sugammadex.
Fernandopulle NA; Zhang SS; Soeding PF; Mackay GA
Clin Exp Allergy; 2021 May; 51(5):685-695. PubMed ID: 33275825
[TBL] [Abstract][Full Text] [Related]
7. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia.
Navinés-Ferrer A; Serrano-Candelas E; Lafuente A; Muñoz-Cano R; Martín M; Gastaminza G
Sci Rep; 2018 Aug; 8(1):11628. PubMed ID: 30072729
[TBL] [Abstract][Full Text] [Related]
8. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2.
Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L
Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196
[TBL] [Abstract][Full Text] [Related]
9. Rocuronium Hypersensitivity: Does Off-Target Occupation of the MRGPRX2 Receptor Play a Role?
Van Gasse AL; Elst J; Bridts CH; Mertens C; Faber M; Hagendorens MM; De Clerck LS; Sabato V; Ebo DG
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):998-1003. PubMed ID: 30315997
[TBL] [Abstract][Full Text] [Related]
10. MRGPRX2 and Adverse Drug Reactions.
McNeil BD
Front Immunol; 2021; 12():676354. PubMed ID: 34421893
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of allergy tests for neuromuscular blocking agents: tackling an unmet need.
Leysen J; Uyttebroek A; Sabato V; Bridts CH; De Clerck LS; Ebo DG
Clin Exp Allergy; 2014 Aug; 44(8):1069-75. PubMed ID: 24848972
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils.
Kvedariene V; Kamey S; Ryckwaert Y; Rongier M; Bousquet J; Demoly P; Arnoux B
Allergy; 2006 Mar; 61(3):311-5. PubMed ID: 16436139
[TBL] [Abstract][Full Text] [Related]
13. Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2).
Kumar M; Duraisamy K; Chow BK
Cells; 2021 Apr; 10(5):. PubMed ID: 33925682
[TBL] [Abstract][Full Text] [Related]
14. Minireview: Mas-related G protein-coupled receptor X2 activation by therapeutic drugs.
McNeil BD
Neurosci Lett; 2021 Apr; 751():135746. PubMed ID: 33610674
[TBL] [Abstract][Full Text] [Related]
15. Recent Knowledge and Insights on the Mechanisms of Immediate Hypersensitivity and Anaphylaxis: IgE/FcεRI- and Non-IgE/FcεRI-Dependent Anaphylaxis.
Ebo DG; Beyens M; Heremans K; van der Poorten MM; Van Gasse AL; Mertens C; Houdt MV; Sabato V; Elst J
Curr Pharm Des; 2023; 29(3):178-184. PubMed ID: 36284380
[TBL] [Abstract][Full Text] [Related]
16. MRGPRX2 is essential for sinomenine hydrochloride induced anaphylactoid reactions.
Liu R; Che D; Zhao T; Pundir P; Cao J; Lv Y; Wang J; Ma P; Fu J; Wang N; Wang X; Zhang T; Dong X; He L
Biochem Pharmacol; 2017 Dec; 146():214-223. PubMed ID: 28987593
[TBL] [Abstract][Full Text] [Related]
17. Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target.
Mackay GA; Fernandopulle NA; Ding J; McComish J; Soeding PF
Front Immunol; 2021; 12():688930. PubMed ID: 34867939
[TBL] [Abstract][Full Text] [Related]
18. Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record-Linked Biobank.
Foer D; Wien M; Karlson EW; Song W; Boyce JA; Brennan PJ
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):492-499.e2. PubMed ID: 36356925
[TBL] [Abstract][Full Text] [Related]
19. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
20. Thimerosal induces skin pseudo-allergic reaction via Mas-related G-protein coupled receptor B2.
Peng B; Che D; Hao Y; Zheng Y; Liu R; Qian Y; Cao J; Wang J; Zhang Y; He L; Geng S
J Dermatol Sci; 2019 Sep; 95(3):99-106. PubMed ID: 31558225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
